Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Sales | 407 | 397 | 471 | 412 | 524 |
| Cost of Goods | 211 | 200 | 214 | 300 | 199 |
| Gross Profit | 196 | 197 | 257 | 112 | 325 |
| Operating Expenses | 1,282 | 1,455 | 1,457 | 1,642 | 1,283 |
| Operating Income | -875 | -1,058 | -986 | -1,230 | -759 |
| Interest Expense | 2 | 2 | 2 | 3 | 1 |
| Other Income | 1 | 0 | -5 | 0 | 0 |
| Pre-tax Income | -876 | -1,060 | -993 | -1,233 | -760 |
| Net Income Continuous | -876 | -1,060 | -993 | -1,233 | -760 |
| Net Income | $-876 | $-1,060 | $-993 | $-1,233 | $-760 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-840 | $-1,021 | $-956 | $-1,179 | $-707 |